Clinical trials
Recruiting Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 3 |
| City of Hope Medical Center | 2 |
| Nurix Therapeutics, Inc. | 2 |
| Accutar Biotechnology Inc | 1 |
| Baylor College of Medicine | 1 |
| C. Babis Andreadis | 1 |
| Carna Biosciences, Inc. | 1 |
| Catapult Therapeutics | 1 |
| CytoCares Inc | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 27 |
| Lymphoma, B-Cell, Marginal Zone | 12 |
| Lymphoma, Non-Hodgkin | 12 |
| Lymphoma, Follicular | 11 |
| Lymphoma, Mantle-Cell | 11 |
| Waldenstrom Macroglobulinemia | 8 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Recurrence | 7 |
| Lymphoma, B-Cell | 6 |
| Burkitt Lymphoma | 5 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.